Corvex, Inc. (NASDAQ:MOVE) Short Interest Update

Corvex, Inc. (NASDAQ:MOVE) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 191,060 shares, an increase of 61.9% from the August 15th total of 118,037 shares. Based on an average daily volume of 671,808 shares, the short-interest ratio is presently 0.3 days. Currently, 0.9% of the shares of the company are sold short.

Corvex Stock Performance

Shares of MOVE opened at $10.11 on Friday. Corvex has a 52-week low of $3.44 and a 52-week high of $26.72. The stock’s 50-day simple moving average is $12.04 and its 200 day simple moving average is $15.31. The company has a debt-to-equity ratio of 4.28, a quick ratio of 1.80 and a current ratio of 1.80. The stock has a market capitalization of $318.97 million, a price-to-earnings ratio of -0.54 and a beta of 0.90.

Corvex (NASDAQ:MOVE) last announced its quarterly earnings results on Friday, August 14th. The AI infrastructure company reported ($5.12) EPS for the quarter, missing the consensus estimate of ($3.17) by ($1.95). The business had revenue of $3.80 million for the quarter, compared to analysts’ expectations of $6.71 million.

Analyst Upgrades and Downgrades

MOVE has been the topic of a number of recent research reports. Chardan Capital set a $18.75 price target on Corvex and gave the company a “buy” rating in a research report on Wednesday. Weiss Ratings raised Corvex from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, September 3rd. Finally, Wall Street Zen upgraded Corvex from a “sell” rating to a “hold” rating in a research note on Sunday, May 24th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, Corvex currently has a consensus rating of “Hold” and a consensus price target of $18.75.

Corvex Company Profile

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.